CAS: 1415925-18-6
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
GSK2795039 REF: TM-T15433CAS: 1415925-18-6 | 95.8% - 98.68% | 72.00 €~874.00 € | Tue 10 Dec 24 | |
GSK2795039 REF: 3D-QGC92518CAS: 1415925-18-6 | Min. 95% | To inquire | Tue 21 Jan 25 | |
N-(1-Isopropyl-3-(1-methylindolin-6-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-methyl-1H-pyrazole-3-sulfonamide REF: IN-DA009CN0CAS: 1415925-18-6 | 97% | - - - | Discontinued product |
GSK2795039
CAS:1415925-18-6
GSK2795039 reduces ROS, NADPH use, apoptosis, and inhibits NOX2 (pIC50: 6).
Formula:
C23H26N6O2S
Purity:
95.8% - 98.68%
Color and Shape:
Solid
Molecular weight:
450.56
Ref: TM-T15433
1mg | 72.00 € | ||
2mg | 95.00 € | ||
5mg | 158.00 € | ||
10mg | 239.00 € | ||
25mg | 420.00 € | ||
50mg | 613.00 € | ||
100mg | 874.00 € | ||
1mL*10mM (DMSO) | 168.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
GSK2795039
CAS:1415925-18-6
GSK2795039 is a molecule that may be a potential therapeutic for hypoxic tumours. GSK2795039 inhibits …
Formula:
C23H26N6O2S
Purity:
Min. 95%
Molecular weight:
450.56 g/mol
Ref: 3D-QGC92518
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
N-(1-Isopropyl-3-(1-methylindolin-6-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-methyl-1H-pyrazole-3-sulfonamide
CAS:1415925-18-6
Formula:
C23H26N6O2S
Purity:
97%
Color and Shape:
Solid
Molecular weight:
450.5565
Ref: IN-DA009CN0
1mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information |